Table: Gene sets enriched in phenotype OIS (2 samples) [plain text format]

	GS follow link to MSigDB	GS DETAILS	SIZE	ES	NES	NOM p-val	FDR q-val	FWER p-val	RANK AT MAX	LEADING EDGE
1	WANG_CISPLATIN_RESPONSE_AND_XPC_DN	Details ...	18	0.71	1.88	0.000	0.165	0.000	86	tags=33%, list=14%, signal=38%
2	ENK_UV_RESPONSE_EPIDERMIS_DN	Details ...	41	0.59	1.88	0.000	0.165	0.165	119	tags=37%, list=19%, signal=42%
3	CHICAS_RB1_TARGETS_SENESCENT	Details ...	31	0.72	1.81	0.000	0.165	0.165	59	tags=42%, list=10%, signal=44%
4	FOURNIER_ACINAR_DEVELOPMENT_LATE_2	Details ...	19	0.74	1.81	0.000	0.165	0.165	49	tags=32%, list=8%, signal=33%
5	BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP	Details ...	23	0.62	1.81	0.000	0.165	0.165	77	tags=35%, list=13%, signal=38%
6	WEI_MYCN_TARGETS_WITH_E_BOX	Details ...	37	0.57	1.78	0.000	0.165	0.165	77	tags=24%, list=13%, signal=26%
7	SENESE_HDAC1_TARGETS_UP	Details ...	23	0.74	1.77	0.000	0.165	0.165	102	tags=57%, list=17%, signal=65%
8	LEE_BMP2_TARGETS_DN	Details ...	50	0.48	1.77	0.000	0.165	0.165	145	tags=38%, list=24%, signal=46%
9	ONDER_CDH1_TARGETS_2_DN	Details ...	21	0.79	1.76	0.000	0.190	0.319	49	tags=43%, list=8%, signal=45%
10	SENESE_HDAC3_TARGETS_UP	Details ...	33	0.71	1.76	0.000	0.188	0.319	102	tags=55%, list=17%, signal=62%
11	SENESE_HDAC1_AND_HDAC2_TARGETS_UP	Details ...	16	0.76	1.75	0.000	0.186	0.319	118	tags=63%, list=19%, signal=75%
12	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	Details ...	38	0.49	1.73	0.000	0.184	0.319	141	tags=32%, list=23%, signal=38%
13	NUYTTEN_NIPP1_TARGETS_UP	Details ...	29	0.52	1.73	0.000	0.182	0.319	45	tags=21%, list=7%, signal=21%
14	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP	Details ...	41	0.57	1.70	0.000	0.201	0.477	112	tags=32%, list=18%, signal=36%
15	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	Details ...	19	0.70	1.69	0.000	0.199	0.477	101	tags=42%, list=16%, signal=49%
16	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	Details ...	51	0.57	1.69	0.000	0.197	0.477	141	tags=41%, list=23%, signal=49%
17	LU_EZH2_TARGETS_DN	Details ...	19	0.60	1.67	0.000	0.195	0.477	53	tags=26%, list=9%, signal=28%
18	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	Details ...	30	0.55	1.66	0.000	0.193	0.477	62	tags=20%, list=10%, signal=21%
19	THUM_SYSTOLIC_HEART_FAILURE_UP	Details ...	21	0.49	1.66	0.000	0.192	0.477	99	tags=24%, list=16%, signal=27%
20	BASAKI_YBX1_TARGETS_DN	Details ...	27	0.62	1.65	0.000	0.190	0.477	48	tags=33%, list=8%, signal=35%
21	HORIUCHI_WTAP_TARGETS_UP		16	0.69	1.65	0.000	0.189	0.477	34	tags=38%, list=6%, signal=39%
22	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF		35	0.60	1.64	0.000	0.188	0.477	119	tags=46%, list=19%, signal=53%
23	BLUM_RESPONSE_TO_SALIRASIB_UP		17	0.62	1.63	0.000	0.187	0.477	127	tags=35%, list=21%, signal=43%
24	LIM_MAMMARY_STEM_CELL_UP		31	0.68	1.63	0.000	0.186	0.477	108	tags=42%, list=18%, signal=48%
25	ONKEN_UVEAL_MELANOMA_UP		41	0.42	1.62	0.000	0.196	0.650	117	tags=22%, list=19%, signal=25%
26	MITSIADES_RESPONSE_TO_APLIDIN_UP		30	0.54	1.62	0.000	0.195	0.650	77	tags=27%, list=13%, signal=29%
27	RIGGI_EWING_SARCOMA_PROGENITOR_DN		15	0.84	1.60	0.000	0.204	0.650	53	tags=53%, list=9%, signal=57%
28	YAGI_AML_WITH_11Q23_REARRANGED		16	0.53	1.59	0.000	0.212	0.650	167	tags=38%, list=27%, signal=50%
29	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN		32	0.59	1.57	0.000	0.239	0.824	62	tags=31%, list=10%, signal=33%
30	GRUETZMANN_PANCREATIC_CANCER_UP		15	0.51	1.56	0.000	0.236	0.824	24	tags=20%, list=4%, signal=20%
31	FOSTER_TOLERANT_MACROPHAGE_DN		24	0.53	1.56	0.000	0.234	0.824	125	tags=42%, list=20%, signal=50%
32	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP		19	0.56	1.55	0.000	0.232	0.824	85	tags=37%, list=14%, signal=41%
33	WEST_ADRENOCORTICAL_TUMOR_UP		15	0.51	1.54	0.000	0.236	0.824	23	tags=13%, list=4%, signal=14%
34	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP		16	0.58	1.53	0.000	0.234	0.824	49	tags=25%, list=8%, signal=26%
35	LINDGREN_BLADDER_CANCER_CLUSTER_2B		22	0.55	1.53	0.000	0.232	0.824	134	tags=41%, list=22%, signal=50%
36	CUI_TCF21_TARGETS_2_DN		39	0.49	1.52	0.000	0.238	0.824	119	tags=36%, list=19%, signal=42%
37	DOUGLAS_BMI1_TARGETS_DN		15	0.44	1.51	0.000	0.236	0.824	58	tags=13%, list=9%, signal=14%
38	GOZGIT_ESR1_TARGETS_DN		30	0.52	1.51	0.000	0.234	0.824	46	tags=27%, list=7%, signal=27%
39	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN		17	0.52	1.50	0.000	0.253	0.824	131	tags=35%, list=21%, signal=44%
40	BENPORATH_SUZ12_TARGETS		39	0.67	1.50	0.000	0.251	0.824	81	tags=36%, list=13%, signal=39%
41	YAGI_AML_WITH_INV_16_TRANSLOCATION		22	0.54	1.49	0.000	0.249	0.824	50	tags=27%, list=8%, signal=29%
42	ENK_UV_RESPONSE_KERATINOCYTE_DN		23	0.50	1.49	0.000	0.247	0.824	43	tags=17%, list=7%, signal=18%
43	BLALOCK_ALZHEIMERS_DISEASE_UP		53	0.40	1.49	0.000	0.245	0.824	43	tags=11%, list=7%, signal=11%
44	BROWNE_HCMV_INFECTION_48HR_DN		17	0.37	1.49	0.000	0.243	0.824	84	tags=18%, list=14%, signal=20%
45	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3		47	0.52	1.48	0.000	0.242	0.824	109	tags=38%, list=18%, signal=43%
46	PASINI_SUZ12_TARGETS_DN		24	0.55	1.48	0.000	0.240	0.824	138	tags=42%, list=22%, signal=52%
47	KIM_WT1_TARGETS_UP		16	0.63	1.48	0.000	0.238	0.824	150	tags=69%, list=24%, signal=89%
48	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF		15	0.60	1.47	0.000	0.254	0.824	86	tags=33%, list=14%, signal=38%
49	BENPORATH_PRC2_TARGETS		27	0.77	1.47	0.000	0.252	0.824	81	tags=44%, list=13%, signal=49%
50	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN		15	0.47	1.47	0.000	0.283	0.824	34	tags=13%, list=6%, signal=14%
51	DELYS_THYROID_CANCER_UP		25	0.69	1.46	0.000	0.281	0.824	48	tags=32%, list=8%, signal=33%
52	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP		20	0.63	1.44	0.000	0.295	0.824	77	tags=40%, list=13%, signal=44%
53	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING		23	0.40	1.44	0.000	0.292	0.824	84	tags=17%, list=14%, signal=19%
54	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3		57	0.37	1.44	0.000	0.290	0.824	107	tags=23%, list=17%, signal=25%
55	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B		27	0.45	1.43	0.000	0.288	0.824	101	tags=33%, list=16%, signal=38%
56	NUYTTEN_EZH2_TARGETS_UP		54	0.40	1.43	0.000	0.285	0.824	77	tags=19%, list=13%, signal=19%
57	CHEN_HOXA5_TARGETS_9HR_UP		21	0.56	1.43	0.000	0.283	0.824	93	tags=29%, list=15%, signal=33%
58	HELLER_HDAC_TARGETS_DN		18	0.52	1.43	0.000	0.281	0.824	131	tags=33%, list=21%, signal=41%
59	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7		20	0.46	1.42	0.000	0.279	0.824	110	tags=40%, list=18%, signal=47%
60	MATSUDA_NATURAL_KILLER_DIFFERENTIATION		18	0.48	1.42	0.000	0.305	0.824	101	tags=33%, list=16%, signal=39%
61	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN		27	0.61	1.41	0.000	0.307	0.824	62	tags=30%, list=10%, signal=32%
62	REACTOME_HEMOSTASIS		20	0.65	1.41	0.000	0.305	0.824	89	tags=35%, list=14%, signal=40%
63	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN		23	0.45	1.41	0.000	0.306	0.824	141	tags=48%, list=23%, signal=60%
64	BLALOCK_ALZHEIMERS_DISEASE_DN		62	0.47	1.41	0.000	0.304	0.824	50	tags=13%, list=8%, signal=13%
65	NABA_MATRISOME_ASSOCIATED		18	0.64	1.41	0.000	0.302	0.824	51	tags=44%, list=8%, signal=47%
66	BENPORATH_ES_WITH_H3K27ME3		33	0.71	1.40	0.000	0.300	0.824	81	tags=39%, list=13%, signal=43%
67	VERHAAK_GLIOBLASTOMA_MESENCHYMAL		16	0.70	1.40	0.000	0.301	0.824	49	tags=31%, list=8%, signal=33%
68	WANG_SMARCE1_TARGETS_DN		26	0.44	1.39	0.000	0.299	0.824	59	tags=23%, list=10%, signal=24%
69	SWEET_LUNG_CANCER_KRAS_UP		20	0.62	1.39	0.000	0.301	0.824	83	tags=25%, list=13%, signal=28%
70	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN		18	0.41	1.39	0.000	0.299	0.824	97	tags=28%, list=16%, signal=32%
71	REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI		36	0.40	1.38	0.000	0.301	0.824	255	tags=69%, list=41%, signal=112%
72	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN		18	0.33	1.37	0.000	0.306	0.824	50	tags=11%, list=8%, signal=12%
73	GARY_CD5_TARGETS_UP		16	0.60	1.37	0.000	0.307	0.824	85	tags=25%, list=14%, signal=28%
74	WANG_MLL_TARGETS		18	0.61	1.37	0.000	0.306	0.824	53	tags=33%, list=9%, signal=35%
75	RODWELL_AGING_KIDNEY_UP		15	0.69	1.37	0.000	0.304	0.824	82	tags=33%, list=13%, signal=38%
76	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN		27	0.50	1.36	0.000	0.302	0.824	141	tags=52%, list=23%, signal=64%
77	BENPORATH_NANOG_TARGETS		46	0.43	1.36	0.000	0.300	0.824	58	tags=15%, list=9%, signal=16%
78	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP		22	0.39	1.36	0.000	0.301	0.824	43	tags=18%, list=7%, signal=19%
79	BENPORATH_MYC_TARGETS_WITH_EBOX		17	0.62	1.35	0.000	0.304	1.000	86	tags=29%, list=14%, signal=33%
80	ZHENG_BOUND_BY_FOXP3		31	0.54	1.35	0.000	0.302	1.000	178	tags=61%, list=29%, signal=82%
81	LI_INDUCED_T_TO_NATURAL_KILLER_UP		18	0.65	1.35	0.000	0.300	1.000	62	tags=33%, list=10%, signal=36%
82	DELACROIX_RAR_BOUND_ES		15	0.67	1.34	0.000	0.313	1.000	136	tags=47%, list=22%, signal=58%
83	SMID_BREAST_CANCER_BASAL_DN		31	0.49	1.34	0.000	0.311	1.000	140	tags=42%, list=23%, signal=52%
84	LOPEZ_MBD_TARGETS		32	0.35	1.34	0.000	0.312	1.000	120	tags=16%, list=20%, signal=18%
85	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6		15	0.37	1.34	0.000	0.318	1.000	50	tags=13%, list=8%, signal=14%
86	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN		37	0.37	1.33	0.000	0.345	1.000	136	tags=30%, list=22%, signal=36%
87	PEDRIOLI_MIR31_TARGETS_DN		18	0.50	1.32	0.000	0.355	1.000	98	tags=28%, list=16%, signal=32%
88	LEE_BMP2_TARGETS_UP		18	0.54	1.32	0.000	0.353	1.000	112	tags=44%, list=18%, signal=53%
89	BENPORATH_SOX2_TARGETS		39	0.48	1.32	0.000	0.351	1.000	32	tags=15%, list=5%, signal=15%
90	MILI_PSEUDOPODIA_HAPTOTAXIS_UP		35	0.49	1.32	0.000	0.358	1.000	111	tags=23%, list=18%, signal=26%
91	NABA_MATRISOME		27	0.57	1.32	0.000	0.356	1.000	84	tags=37%, list=14%, signal=41%
92	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP		17	0.39	1.32	0.000	0.354	1.000	51	tags=18%, list=8%, signal=19%
93	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN		21	0.46	1.31	0.000	0.352	1.000	173	tags=43%, list=28%, signal=58%
94	HAN_SATB1_TARGETS_UP		19	0.53	1.31	0.000	0.350	1.000	3	tags=5%, list=0%, signal=5%
95	ENK_UV_RESPONSE_KERATINOCYTE_UP		26	0.51	1.31	0.000	0.348	1.000	98	tags=31%, list=16%, signal=35%
96	OSMAN_BLADDER_CANCER_UP		19	0.51	1.31	0.000	0.346	1.000	9	tags=11%, list=1%, signal=10%
97	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP		22	0.38	1.30	0.000	0.344	1.000	23	tags=9%, list=4%, signal=9%
98	WEST_ADRENOCORTICAL_TUMOR_DN		18	0.63	1.30	0.000	0.342	1.000	109	tags=33%, list=18%, signal=39%
99	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D		37	0.44	1.30	0.000	0.351	1.000	53	tags=14%, list=9%, signal=14%
100	WP_VEGFAVEGFR2_SIGNALING_PATHWAY		25	0.57	1.29	0.000	0.352	1.000	24	tags=12%, list=4%, signal=12%
101	KRIEG_HYPOXIA_NOT_VIA_KDM3A		38	0.50	1.29	0.000	0.353	1.000	115	tags=37%, list=19%, signal=43%
102	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		19	0.47	1.29	0.000	0.351	1.000	84	tags=26%, list=14%, signal=30%
103	BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP		26	0.73	1.28	0.000	0.349	1.000	75	tags=50%, list=12%, signal=55%
104	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP		16	0.43	1.28	0.000	0.347	1.000	206	tags=38%, list=33%, signal=55%
105	BERENJENO_TRANSFORMED_BY_RHOA_UP		28	0.63	1.28	0.000	0.346	1.000	26	tags=18%, list=4%, signal=18%
106	BENPORATH_EED_TARGETS		40	0.63	1.27	0.000	0.353	1.000	81	tags=35%, list=13%, signal=38%
107	REACTOME_SIGNALING_BY_GPCR		16	0.67	1.26	0.000	0.359	1.000	129	tags=56%, list=21%, signal=69%
108	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP		25	0.52	1.26	0.000	0.359	1.000	68	tags=32%, list=11%, signal=35%
109	WANG_TUMOR_INVASIVENESS_UP		20	0.42	1.26	0.000	0.358	1.000	208	tags=55%, list=34%, signal=80%
110	REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES		22	0.65	1.26	0.000	0.358	1.000	110	tags=45%, list=18%, signal=53%
111	VANTVEER_BREAST_CANCER_ESR1_DN		15	0.61	1.26	0.000	0.357	1.000	83	tags=40%, list=13%, signal=45%
112	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN		26	0.56	1.26	0.000	0.355	1.000	157	tags=38%, list=26%, signal=49%
113	MOOTHA_PGC		18	0.49	1.26	0.000	0.353	1.000	32	tags=11%, list=5%, signal=11%
114	RIGGI_EWING_SARCOMA_PROGENITOR_UP		25	0.61	1.26	0.000	0.352	1.000	130	tags=56%, list=21%, signal=68%
115	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP		34	0.44	1.25	0.000	0.361	1.000	118	tags=29%, list=19%, signal=34%
116	GROSS_HYPOXIA_VIA_ELK3_DN		20	0.66	1.25	0.000	0.359	1.000	65	tags=30%, list=11%, signal=32%
117	REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS		15	0.75	1.25	0.000	0.381	1.000	51	tags=40%, list=8%, signal=43%
118	DURCHDEWALD_SKIN_CARCINOGENESIS_DN		17	0.43	1.25	0.000	0.379	1.000	118	tags=29%, list=19%, signal=35%
119	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP		16	0.50	1.25	0.000	0.377	1.000	119	tags=44%, list=19%, signal=53%
120	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN		26	0.49	1.24	0.000	0.386	1.000	131	tags=35%, list=21%, signal=42%
121	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3		21	0.27	1.24	0.000	0.398	1.000	160	tags=29%, list=26%, signal=37%
122	BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP		19	0.54	1.23	0.000	0.399	1.000	77	tags=32%, list=13%, signal=35%
123	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4		15	0.54	1.23	0.000	0.399	1.000	119	tags=40%, list=19%, signal=48%
124	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN		15	0.42	1.23	0.000	0.397	1.000	247	tags=60%, list=40%, signal=98%
125	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN		17	0.51	1.23	0.000	0.397	1.000	56	tags=18%, list=9%, signal=19%
126	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN		18	0.45	1.23	0.000	0.395	1.000	56	tags=17%, list=9%, signal=18%
127	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP		18	0.46	1.22	0.000	0.404	1.000	102	tags=28%, list=17%, signal=32%
128	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN		39	0.27	1.22	0.000	0.411	1.000	217	tags=44%, list=35%, signal=63%
129	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN		32	0.58	1.22	0.000	0.412	1.000	59	tags=19%, list=10%, signal=20%
130	CHEN_METABOLIC_SYNDROM_NETWORK		51	0.38	1.22	0.000	0.410	1.000	110	tags=25%, list=18%, signal=28%
131	MOHANKUMAR_HOXA1_TARGETS_UP		16	0.35	1.21	0.000	0.423	1.000	227	tags=56%, list=37%, signal=87%
132	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION		42	0.40	1.21	0.000	0.426	1.000	88	tags=17%, list=14%, signal=18%
133	PUJANA_ATM_PCC_NETWORK		49	0.36	1.20	0.000	0.426	1.000	148	tags=31%, list=24%, signal=37%
134	JOHNSTONE_PARVB_TARGETS_3_UP		16	0.57	1.19	0.000	0.426	1.000	49	tags=19%, list=8%, signal=20%
135	MILI_PSEUDOPODIA_HAPTOTAXIS_DN		31	0.49	1.19	0.000	0.424	1.000	120	tags=23%, list=20%, signal=27%
136	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3		35	0.55	1.19	0.000	0.424	1.000	118	tags=40%, list=19%, signal=47%
137	GENTILE_UV_HIGH_DOSE_DN		27	0.45	1.19	0.000	0.422	1.000	141	tags=41%, list=23%, signal=51%
138	REACTOME_NERVOUS_SYSTEM_DEVELOPMENT		24	0.46	1.19	0.000	0.427	1.000	214	tags=50%, list=35%, signal=74%
139	MARTINEZ_RB1_TARGETS_UP		28	0.43	1.18	0.000	0.438	1.000	220	tags=61%, list=36%, signal=90%
140	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP		16	0.35	1.17	0.000	0.448	1.000	56	tags=13%, list=9%, signal=13%
141	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP		29	0.30	1.16	0.000	0.448	1.000	105	tags=21%, list=17%, signal=24%
142	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN		48	0.30	1.16	0.313	0.452	1.000	141	tags=33%, list=23%, signal=40%
143	KIM_ALL_DISORDERS_CALB1_CORR_UP		26	0.39	1.16	0.337	0.450	1.000	50	tags=12%, list=8%, signal=12%
144	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES		18	0.50	1.16	0.000	0.448	1.000	237	tags=61%, list=39%, signal=97%
145	ZHANG_BREAST_CANCER_PROGENITORS_UP		20	0.24	1.16	0.000	0.448	1.000	138	tags=30%, list=22%, signal=37%
146	MEBARKI_HCC_PROGENITOR_WNT_UP		15	0.38	1.16	0.000	0.453	1.000	130	tags=40%, list=21%, signal=49%
147	PEREZ_TP63_TARGETS		15	0.64	1.15	0.000	0.451	1.000	51	tags=33%, list=8%, signal=35%
148	KOYAMA_SEMA3B_TARGETS_UP		15	0.50	1.14	0.313	0.469	1.000	100	tags=33%, list=16%, signal=39%
149	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP		17	0.55	1.14	0.000	0.467	1.000	58	tags=29%, list=9%, signal=32%
150	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP		31	0.44	1.14	0.000	0.465	1.000	139	tags=32%, list=23%, signal=40%
151	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP		16	0.58	1.13	0.353	0.466	1.000	65	tags=25%, list=11%, signal=27%
152	REACTOME_INNATE_IMMUNE_SYSTEM		28	0.50	1.13	0.342	0.486	1.000	75	tags=25%, list=12%, signal=27%
153	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN		19	0.25	1.13	0.000	0.484	1.000	74	tags=11%, list=12%, signal=12%
154	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM		20	0.50	1.12	0.331	0.492	1.000	17	tags=15%, list=3%, signal=15%
155	PEREZ_TP53_TARGETS		34	0.51	1.11	0.342	0.490	1.000	86	tags=29%, list=14%, signal=32%
156	ONDER_CDH1_TARGETS_2_UP		18	0.48	1.11	0.000	0.488	1.000	110	tags=33%, list=18%, signal=39%
157	BAELDE_DIABETIC_NEPHROPATHY_DN		32	0.39	1.11	0.000	0.488	1.000	13	tags=9%, list=2%, signal=9%
158	SMID_BREAST_CANCER_NORMAL_LIKE_UP		15	0.62	1.10	0.342	0.503	1.000	109	tags=60%, list=18%, signal=71%
159	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP		16	0.31	1.10	0.331	0.501	1.000	125	tags=25%, list=20%, signal=31%
160	FEVR_CTNNB1_TARGETS_DN		29	0.31	1.09	0.000	0.504	1.000	157	tags=28%, list=26%, signal=35%
161	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN		20	0.37	1.09	0.317	0.509	1.000	99	tags=25%, list=16%, signal=29%
162	BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP		28	0.50	1.09	0.337	0.509	1.000	77	tags=29%, list=13%, signal=31%
163	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR		19	0.43	1.09	0.313	0.507	1.000	140	tags=42%, list=23%, signal=53%
164	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL		19	0.49	1.08	0.000	0.520	1.000	105	tags=32%, list=17%, signal=37%
165	KIM_WT1_TARGETS_12HR_DN		18	0.39	1.08	0.000	0.517	1.000	157	tags=33%, list=26%, signal=43%
166	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN		31	0.33	1.08	0.331	0.515	1.000	62	tags=13%, list=10%, signal=14%
167	ACEVEDO_LIVER_CANCER_DN		15	0.63	1.07	0.000	0.513	1.000	140	tags=47%, list=23%, signal=59%
168	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN		18	0.38	1.07	0.317	0.511	1.000	185	tags=39%, list=30%, signal=54%
169	REACTOME_DEVELOPMENTAL_BIOLOGY		37	0.40	1.07	0.000	0.517	1.000	82	tags=19%, list=13%, signal=21%
170	REACTOME_INFECTIOUS_DISEASE		31	0.43	1.07	0.342	0.515	1.000	222	tags=55%, list=36%, signal=81%
171	MARTINEZ_RB1_AND_TP53_TARGETS_UP		24	0.41	1.06	0.317	0.513	1.000	208	tags=54%, list=34%, signal=79%
172	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN		37	0.29	1.06	0.313	0.519	1.000	45	tags=11%, list=7%, signal=11%
173	LIU_PROSTATE_CANCER_DN		16	0.41	1.06	0.323	0.529	1.000	16	tags=13%, list=3%, signal=12%
174	DODD_NASOPHARYNGEAL_CARCINOMA_DN		51	0.30	1.05	0.323	0.546	1.000	58	tags=8%, list=9%, signal=8%
175	MARTENS_TRETINOIN_RESPONSE_UP		22	0.50	1.05	0.352	0.544	1.000	81	tags=32%, list=13%, signal=35%
176	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP		73	0.30	1.04	0.000	0.554	1.000	193	tags=30%, list=31%, signal=39%
177	COLINA_TARGETS_OF_4EBP1_AND_4EBP2		19	0.54	1.04	0.000	0.553	1.000	75	tags=21%, list=12%, signal=23%
178	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP		20	0.33	1.04	0.342	0.552	1.000	6	tags=5%, list=1%, signal=5%
179	RUTELLA_RESPONSE_TO_HGF_UP		19	0.46	1.04	0.352	0.551	1.000	102	tags=26%, list=17%, signal=31%
180	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR		24	0.25	1.03	0.352	0.569	1.000	190	tags=33%, list=31%, signal=46%
181	FORTSCHEGGER_PHF8_TARGETS_DN		31	0.29	1.03	0.337	0.572	1.000	129	tags=23%, list=21%, signal=27%
182	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		50	0.32	1.03	0.000	0.574	1.000	127	tags=24%, list=21%, signal=28%
183	BENPORATH_CYCLING_GENES		26	0.38	1.02	0.323	0.576	1.000	31	tags=12%, list=5%, signal=12%
184	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN		21	0.34	1.01	0.353	0.577	1.000	77	tags=24%, list=13%, signal=26%
185	YOSHIMURA_MAPK8_TARGETS_UP		34	0.47	1.01	0.317	0.583	1.000	43	tags=21%, list=7%, signal=21%
186	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN		33	0.25	1.01	0.353	0.590	1.000	217	tags=42%, list=35%, signal=62%
187	SMID_BREAST_CANCER_LUMINAL_B_DN		27	0.39	1.00	0.317	0.603	1.000	125	tags=33%, list=20%, signal=40%
188	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP		24	0.55	0.99	0.353	0.606	1.000	124	tags=46%, list=20%, signal=55%
189	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN		35	0.38	0.99	0.353	0.611	1.000	118	tags=26%, list=19%, signal=30%
190	MASSARWEH_TAMOXIFEN_RESISTANCE_UP		21	0.27	0.99	0.317	0.609	1.000	145	tags=33%, list=24%, signal=42%
191	MOOTHA_HUMAN_MITODB_6_2002		25	0.30	0.98	0.353	0.608	1.000	217	tags=40%, list=35%, signal=59%
192	FEVR_CTNNB1_TARGETS_UP		27	0.43	0.98	0.337	0.613	1.000	83	tags=19%, list=13%, signal=20%
193	RAO_BOUND_BY_SALL4_ISOFORM_B		16	0.29	0.98	0.342	0.617	1.000	86	tags=13%, list=14%, signal=14%
194	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN		20	0.24	0.98	0.317	0.619	1.000	91	tags=10%, list=15%, signal=11%
195	ACEVEDO_LIVER_CANCER_UP		47	0.30	0.97	0.331	0.617	1.000	48	tags=9%, list=8%, signal=9%
196	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN		23	0.36	0.97	0.679	0.620	1.000	141	tags=30%, list=23%, signal=38%
197	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A		31	0.36	0.97	0.342	0.618	1.000	60	tags=16%, list=10%, signal=17%
198	MARTINEZ_TP53_TARGETS_DN		30	0.32	0.96	0.665	0.625	1.000	220	tags=57%, list=36%, signal=84%
199	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP		16	0.32	0.95	0.337	0.626	1.000	133	tags=25%, list=22%, signal=31%
200	PUJANA_BRCA1_PCC_NETWORK		54	0.28	0.95	0.313	0.624	1.000	146	tags=28%, list=24%, signal=33%
201	HAMAI_APOPTOSIS_VIA_TRAIL_UP		29	0.36	0.94	0.669	0.651	1.000	84	tags=17%, list=14%, signal=19%
202	KOYAMA_SEMA3B_TARGETS_DN		19	0.43	0.93	0.353	0.655	1.000	141	tags=42%, list=23%, signal=53%
203	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN		21	0.32	0.93	0.313	0.662	1.000	50	tags=14%, list=8%, signal=15%
204	DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP		16	0.30	0.92	0.679	0.671	1.000	143	tags=44%, list=23%, signal=56%
205	MOOTHA_MITOCHONDRIA		24	0.26	0.92	0.353	0.670	1.000	239	tags=42%, list=39%, signal=65%
206	REACTOME_TRANSPORT_OF_SMALL_MOLECULES		24	0.32	0.91	0.313	0.672	1.000	80	tags=21%, list=13%, signal=23%
207	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN		16	0.50	0.90	0.665	0.690	1.000	41	tags=25%, list=7%, signal=26%
208	ODONNELL_TFRC_TARGETS_UP		15	0.55	0.90	0.352	0.690	1.000	75	tags=33%, list=12%, signal=37%
209	MARTINEZ_RB1_AND_TP53_TARGETS_DN		30	0.28	0.90	0.665	0.691	1.000	157	tags=33%, list=26%, signal=43%
210	BENPORATH_OCT4_TARGETS		17	0.44	0.89	0.669	0.703	1.000	195	tags=53%, list=32%, signal=75%
211	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL		17	0.26	0.89	0.313	0.707	1.000	15	tags=6%, list=2%, signal=6%
212	DODD_NASOPHARYNGEAL_CARCINOMA_UP		45	0.38	0.89	0.665	0.704	1.000	129	tags=36%, list=21%, signal=42%
213	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP		19	0.34	0.88	0.669	0.710	1.000	214	tags=53%, list=35%, signal=78%
214	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP		18	0.45	0.88	0.353	0.707	1.000	128	tags=50%, list=21%, signal=61%
215	REACTOME_METABOLISM_OF_LIPIDS		25	0.31	0.88	0.342	0.707	1.000	96	tags=16%, list=16%, signal=18%
216	WP_NUCLEAR_RECEPTORS_METAPATHWAY		16	0.46	0.88	0.669	0.714	1.000	43	tags=19%, list=7%, signal=20%
217	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP		22	0.26	0.86	0.665	0.738	1.000	212	tags=41%, list=34%, signal=60%
218	GEORGES_TARGETS_OF_MIR192_AND_MIR215		30	0.33	0.86	0.654	0.751	1.000	60	tags=17%, list=10%, signal=18%
219	MARSON_BOUND_BY_FOXP3_STIMULATED		52	0.25	0.86	0.323	0.749	1.000	93	tags=15%, list=15%, signal=17%
220	MARTENS_BOUND_BY_PML_RARA_FUSION		27	0.29	0.86	0.665	0.747	1.000	147	tags=37%, list=24%, signal=47%
221	PILON_KLF1_TARGETS_UP		18	0.32	0.85	0.669	0.757	1.000	127	tags=28%, list=21%, signal=34%
222	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5		21	0.28	0.84	0.669	0.771	1.000	99	tags=24%, list=16%, signal=27%
223	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN		37	0.21	0.84	0.654	0.774	1.000	70	tags=8%, list=11%, signal=9%
224	BRUINS_UVC_RESPONSE_LATE		62	0.21	0.84	0.654	0.771	1.000	111	tags=15%, list=18%, signal=16%
225	GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN		37	0.43	0.83	0.665	0.780	1.000	23	tags=14%, list=4%, signal=13%
226	BRUINS_UVC_RESPONSE_EARLY_LATE		18	0.38	0.83	0.323	0.779	1.000	33	tags=11%, list=5%, signal=11%
227	REACTOME_SIGNALING_BY_INTERLEUKINS		15	0.38	0.83	0.331	0.776	1.000	83	tags=27%, list=13%, signal=30%
228	MARTINEZ_TP53_TARGETS_UP		23	0.33	0.82	0.669	0.790	1.000	142	tags=30%, list=23%, signal=38%
229	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP		16	0.30	0.82	0.313	0.791	1.000	169	tags=38%, list=27%, signal=50%
230	CUI_TCF21_TARGETS_2_UP		22	0.22	0.80	0.669	0.801	1.000	16	tags=5%, list=3%, signal=4%
231	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY		35	0.34	0.80	0.679	0.800	1.000	117	tags=31%, list=19%, signal=37%
232	HSIAO_HOUSEKEEPING_GENES		22	0.30	0.80	0.352	0.797	1.000	215	tags=41%, list=35%, signal=61%
233	REACTOME_METABOLISM_OF_RNA		34	0.22	0.80	0.665	0.795	1.000	256	tags=50%, list=42%, signal=81%
234	DANG_BOUND_BY_MYC		59	0.20	0.80	0.654	0.792	1.000	43	tags=5%, list=7%, signal=5%
235	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP		34	0.26	0.79	0.654	0.812	1.000	34	tags=6%, list=6%, signal=6%
236	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION		61	0.20	0.78	0.665	0.811	1.000	163	tags=25%, list=27%, signal=30%
237	MARSON_BOUND_BY_FOXP3_UNSTIMULATED		57	0.29	0.77	0.665	0.832	1.000	105	tags=21%, list=17%, signal=23%
238	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP		17	0.30	0.76	0.352	0.855	1.000	79	tags=12%, list=13%, signal=13%
239	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS		15	0.26	0.74	0.665	0.869	1.000	120	tags=20%, list=20%, signal=24%
240	MARTENS_TRETINOIN_RESPONSE_DN		42	0.23	0.73	0.665	0.869	1.000	198	tags=33%, list=32%, signal=46%
241	DOUGLAS_BMI1_TARGETS_UP		24	0.31	0.72	0.665	0.875	1.000	59	tags=13%, list=10%, signal=13%
242	WANG_SMARCE1_TARGETS_UP		22	0.18	0.72	0.654	0.876	1.000	218	tags=32%, list=35%, signal=48%
243	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS		23	0.39	0.72	0.669	0.877	1.000	51	tags=17%, list=8%, signal=18%
244	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN		15	0.29	0.71	0.669	0.882	1.000	157	tags=33%, list=26%, signal=44%
245	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS		76	0.26	0.71	0.665	0.880	1.000	45	tags=8%, list=7%, signal=7%
246	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR		15	0.21	0.65	0.654	0.925	1.000	135	tags=27%, list=22%, signal=33%
247	OSMAN_BLADDER_CANCER_DN		32	0.36	0.65	0.665	0.928	1.000	216	tags=53%, list=35%, signal=78%
248	REACTOME_TRANSLATION		16	0.20	0.62	0.665	0.939	1.000	215	tags=44%, list=35%, signal=66%
249	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION		16	0.24	0.60	0.679	0.951	1.000	122	tags=13%, list=20%, signal=15%
250	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION		16	0.24	0.60	0.679	0.947	1.000	122	tags=13%, list=20%, signal=15%
251	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN		23	0.17	0.54	0.665	0.968	1.000	192	tags=26%, list=31%, signal=37%